NR4A2-mediated regulation of IL-17-producing T cells for novel therapeutic strategy of autoimmune diseases
| Project/Area Number |
21590087
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Biological pharmacy
|
|---|
| Research Institution | National Center of Neurology and Psychiatry |
|---|
Principal Investigator |
OKI Shinji 独立行政法人国立精神・神経医療研究センター, 神経研究所疾病研究第六部, 第三研究室長 (50260328)
|
|---|
| Project Period (FY) |
2009 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2009: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
|---|
| Keywords | 自己免疫疾患 / 核内受容体 / Th17細胞 / 多発性硬化症 / NR4A2 / インターロイキン17 / バイオマーカー |
|---|
| Research Abstract |
We identified the orphan nuclear receptor NR4A2 as a most significantly upregulated gene in peripheral T cells obtained from MS patients by microarray analysis. Further analysis employing experimental autoimmune encepharomyelitis(EAE) revealed that NR4A2 expression is selectively associated with IL-17-producing pathogenic T cells and preventive intervention for NR4A2 function ameliorates EAE symptom.
|
Report
(4 results)
Research Products
(43 results)
